1. Home
  2. PRAX vs BLDR Comparison

PRAX vs BLDR Comparison

Compare PRAX & BLDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$327.25

Market Cap

7.1B

Sector

Health Care

ML Signal

N/A

Logo Builders FirstSource Inc.

BLDR

Builders FirstSource Inc.

N/A

Current Price

$66.62

Market Cap

7.5B

ML Signal

N/A

Company Overview

Basic Information
Metric
PRAX
BLDR
Founded
2015
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
RETAIL: Building Materials
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
7.5B
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
PRAX
BLDR
Price
$327.25
$66.62
Analyst Decision
Strong Buy
Hold
Analyst Count
21
24
Target Price
★ $650.00
$67.45
AVG Volume (30 Days)
420.7K
★ 2.8M
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.08
Revenue
N/A
★ $15,190,638,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$41,442.59
N/A
P/E Ratio
★ N/A
$782.88
Revenue Growth
N/A
★ N/A
52 Week Low
$160.11
$49.67
52 Week High
$392.70
$131.50

Technical Indicators

Market Signals
Indicator
PRAX
BLDR
Relative Strength Index (RSI) 63.91 59.38
Support Level $307.93 $65.91
Resistance Level $347.63 $78.13
Average True Range (ATR) 16.67 3.29
MACD 5.68 1.08
Stochastic Oscillator 96.95 76.79

Price Performance

Historical Comparison
PRAX
BLDR

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About BLDR Builders FirstSource Inc.

Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.

Share on Social Networks: